Sign in or create an account to add this stock to your watchlist.
About Geovax Labs (OTCMKTS:GOVX)
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines for infectious diseases and cancer in the United States and internationally. The company through its patented Modified Vaccinia Ankara-Virus Like Particle vaccine platform develops various vaccines. It is developing various vaccines that are in human clinical trials, and preclinical research and development phases, including vaccines against human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for chronic Hepatitis B infections and cancers. The company has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; the HIV Vaccines Trial Network; Centers for Disease Control and Prevention; United States Army Research Institute of Infectious Disease; U.S. Naval Research Laboratory; Emory University; University of Pittsburgh; Georgia State University Research Foundation; Peking University; University of Texas Medical Branch; the Institute of Human Virology at the University of Maryland; the Scripps Research Institute; the Burnet Institute; American Gene Technologies, Inc.; Viamune, Inc.; Vaxeal Holding SA; and CaroGen Corporation. GeoVax Labs, Inc. was founded in 2001 and is based in Smyrna, Georgia.
Industry, Sector and Symbol
Industry Commercial physical research
Trailing P/E Ratio-1.27
Forward P/E Ratio-1.90
Sales & Book Value
Annual Sales$1.08 million
Price / Sales5.34
Price / CashN/A
Book Value($0.01) per share
Price / Book-3.80
EPS (Most Recent Fiscal Year)($0.03)
Return on EquityN/A
Return on Assets-320.57%
Geovax Labs (OTCMKTS:GOVX) Frequently Asked Questions
What is Geovax Labs' stock symbol?
Geovax Labs trades on the OTCMKTS under the ticker symbol "GOVX."
How were Geovax Labs' earnings last quarter?
Geovax Labs Inc (OTCMKTS:GOVX) posted its earnings results on Thursday, May, 3rd. The biotechnology company reported ($0.01) EPS for the quarter. The biotechnology company earned $0.22 million during the quarter. View Geovax Labs' Earnings History.
When is Geovax Labs' next earnings date?
Who are some of Geovax Labs' key competitors?
Who are Geovax Labs' key executives?
Geovax Labs' management team includes the folowing people:
- Dr. Robert T. McNally Ph.D., Pres, Chief Exec. Officer & Director (Age 70)
- Dr. Harriet Latham Robinson Ph.D., Co-Founder, Chief Scientific Officer Emeritus & Director (Age 80)
- Mr. Mark W. Reynolds, CFO & Corp. Sec. (Age 56)
- Dr. Farshad Guirakhoo Ph.D., Chief Scientific Officer (Age 65)
- Mr. Donald G. Hildebrand, Founder, Chairman Emeritus and Consultant (Age 77)
Has Geovax Labs been receiving favorable news coverage?
Media stories about GOVX stock have trended somewhat positive recently, according to Accern. Accern rates the sentiment of media coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Geovax Labs earned a media sentiment score of 0.17 on Accern's scale. They also gave news stories about the biotechnology company an impact score of 46.43 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the near future.
Who are Geovax Labs' major shareholders?
How do I buy shares of Geovax Labs?
Shares of GOVX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Geovax Labs' stock price today?
One share of GOVX stock can currently be purchased for approximately $0.0380.
How big of a company is Geovax Labs?
Geovax Labs has a market capitalization of $5.69 million and generates $1.08 million in revenue each year. The biotechnology company earns $-2,170,000.00 in net income (profit) each year or ($0.03) on an earnings per share basis. Geovax Labs employs 9 workers across the globe.
How can I contact Geovax Labs?
Geovax Labs' mailing address is 1900 LAKE PARK DRIVE SUITE 380, SMYRNA GA, 30080. The biotechnology company can be reached via phone at 678-384-7220 or via email at [email protected]
MarketBeat Community Rating for Geovax Labs (GOVX)MarketBeat's community ratings are surveys of what our community members think about Geovax Labs and other stocks. Vote "Outperform" if you believe GOVX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GOVX will underperform the S&P 500 over the long term. You may vote once every thirty days.
Geovax Labs (OTCMKTS:GOVX) Analyst Ratings History
(Data available from 5/24/2016 forward)
Geovax Labs (OTCMKTS:GOVX) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Geovax Labs (OTCMKTS GOVX) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 2.10%
Institutional Ownership Percentage: 0.07%
Geovax Labs (OTCMKTS GOVX) Insider Trading History
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|5/5/2015||Randal D Chase||Director||Buy||10,000||$0.19||$1,900.00|| |
|4/23/2015||Mark Reynolds||CFO||Buy||30,000||$0.17||$5,100.00|| |
|4/20/2015||Randal D Chase||Director||Buy||30,000||$0.17||$5,100.00|| |
Geovax Labs (OTCMKTS GOVX) News Headlines
Geovax Labs (OTCMKTS:GOVX) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Geovax Labs (OTCMKTS:GOVX) Income Statement, Balance Sheet and Cash Flow Statement
Geovax Labs (OTCMKTS GOVX) Stock Chart for Thursday, May, 24, 2018